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Trabecular bone organoids: a micron-scale ‘humanised’
prototype designed to study the effects of microgravity
and degeneration
Alexandra Iordachescu 1,2✉, Erik A. B. Hughes1,2, Stephan Joseph1,3, Eric J. Hill 4, Liam M. Grover1,2 and Anthony D. Metcalfe 1,2
Bone is a highly responsive organ, which continuously adapts to the environment it is subjected to in order to withstand metabolic
demands. These events are difficult to study in this particular tissue in vivo, due to its rigid, mineralised structure and inaccessibility
of the cellular component located within. This manuscript presents the development of a micron-scale bone organoid prototype, a
concept that can allow the study of bone processes at the cell-tissue interface. The model is constructed with a combination of
primary female osteoblastic and osteoclastic cells, seeded onto femoral head micro-trabeculae, where they recapitulate relevant
phenotypes and functions. Subsequently, constructs are inserted into a simulated microgravity bioreactor (NASA-Synthecon) to
model a pathological state of reduced mechanical stimulation. In these constructs, we detected osteoclastic bone resorption sites,
which were different in morphology in the simulated microgravity group compared to static controls. Once encapsulated in human
fibrin and exposed to analogue microgravity for 5 days, masses of bone can be observed being lost from the initial structure,
allowing to simulate the bone loss process further. Constructs can function as multicellular, organotypic units. Large osteocytic
projections and tubular structures develop from the initial construct into the matrix at the millimetre scale. Micron-level fragments
from the initial bone structure are detected travelling along these tubules and carried to sites distant from the native structure,
where new matrix formation is initiated. We believe this model allows the study of fine-level physiological processes, which can
shed light into pathological bone loss and imbalances in bone remodelling.
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INTRODUCTION
Bone is an organ that is extremely dynamic and adaptive to its
environment, a form of skeletal plasticity shaped by gravity, which
has evolutionarily generated changes in all amphibious, terrestrial
and volant organisms. Across species, these structural adaptations
always manifest in either the densification or reduction of bone
content in response to mechanical loads, ranging from pneuma-
tisation of this tissue in volant species to reduce the metabolic
costs of powered flight1 to osteological densification in land
tetrapods invading secondary, such as aquatic niches2. In the
human skeleton, the development of superior biomechanics
allowing verticalisation, including curvatures of the spine, long
and hip bone development, meant that the anatomic design was
also a variable strategy to increased metabolic and mechanical
demands. These adaptations can be seen at multiple scales, most
importantly in the micro-structural design as a result of weight
distribution. The acting tensile and compressive forces directed
that bone was organised at the tissue level in two patterns of
arrangement to mechanically support against a wide spectrum of
distortive forces. Cortical bone, lining the outside of skeletal
structures, manages compressive and tensile forces acting
vertically. Within the borders of these cortices, trabecular bone
is contained, an essential type of porous tissue mainly present at
sites of great mechanical stress, such as the femoral head, where
mechanical transfer of weight to the lower limbs takes place
(Fig. 1a, b). The trabecular system contains a network of rods, a
distribution that allows this organ to withstand forces acting from
multiple directions, including bending forces (Fig. 1b). At the
micron scale, this is evident as each trabeculae has a lamellar
structure that is aligned biochemically with its direction3. Because
of such thorough mechanical adaptations, this type of bone tissue
is also extremely prone to changes caused by reduced mechanical
stimulation. In many clinical contexts such as disuse osteoporosis4,
ageing5, spinal cord injury6, immobilisation in bedridden/para-
plegic patients7 and weightlessness experienced by space crews
in microgravity8, a rapid and significant loss in bone mass in the
load-bearing regions takes place (including lower limbs, spine and
hip), increasing the risk of fractures9 and impairing the healing
process10. In all contexts, a similar osteopenic to osteoporotic-type
gradual loss of mineral takes place, leading to a reduction in
trabecular bone density and a porous appearance.
These pathological contexts are difficult to study using current
technologies for numerous reasons. Prolonged bed-rest studies in
human subjects provide useful physiological data11,12, however,
most often, the thresholds in experimental design have to be
lowered to minimise long-term damage such as alterations in
cardiovascular function13. In contrast, there are well-established
animal models for studying musculoskeletal disuse and bone loss.
Rodent models are a frequent choice14 and involve either
hormonal interventions, including surgical excision of ovaries15,
hypophysis16,17 or parathyroid glands18; chemical interventions
(diet low in calcium or toxin injection19), immobilisation, or a
combination of these methods20,21, thus removing structures or
glands that play a key role in supporting the bone formation
process. This is not always desirable, as applying hormonal
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interventions will likely cause sensorimotor impairment and
premature ageing of animals22,23. Immobilisation can involve
surgical resection of nerves24, tendons25 or the spinal cord26.
Some of the more conservative methods involve limb casting or
bandaging, but most often use a suspension method, where the
tails of animals are attached to the roofs of their habitat cages27,28.
This facilitates hindlimb unloading for significant periods of time
and encourages mobility using the front limbs. One major issue
with this technique is that the distress caused by tail-handling29 is
detrimental not only to the animal used, but could interfere with
the secretome being investigated, as fight-or-flight responses are
also mediated through hormonal secretion by bone30. In addition,
the translation of findings to human patient outcomes is difficult,
due to differences in anatomical design and weight distribution, in
the bone remodelling process between the species14 and
between strains of the same species19. This can be a major
bottleneck in the search for promising therapeutics for osteo-
porosis and related conditions.
Lastly, the bone formation process is extremely difficult to study
in vivo and ex vivo due to its highly mineralised nature, which is
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impenetrable and binds many chromogenic agents and as such
requires destruction in order to detect internal histological
features. This invasive processing often leads to the destruction
of the embedded cellular network, which is vital for understanding
the tissue hierarchy and the way cells convert mechanical stimuli
into biochemical signals.
At the cellular level, bone formation is temporarily and spatially
coupled, relying on the balance between bone effector cells—the
tissue building osteoblasts, their mature phenotype (osteocytes),
and the non-native bone resorbing osteoclasts derived from
monocyte precursors; all under the effect of mechanical stimula-
tion, which is then translated into signalling routes involving
hormones and other endocrine organs. Such a microenvironment
is therefore very difficult to replicate in a laboratory setting and
new ex vivo models recapitulating bone remodelling events are
highly needed to overcome these limitations and complement
existing systems.
Organoids and organotypic cultures are becoming an increas-
ingly complex platform for replicating anatomical structures
similar to human organs, which are unique as they are self-
organising and develop features that can be exploited to
understand disruptions in molecular pathways that lead to
disease. They also have significant advantages for applications in
drugs screening and personalised medicine due to their reduced
size, allowing for mass applications and numerous permutations
of subjected conditions. Over the recent years, various methodol-
ogies have been optimised to develop different organoid
constructs resembling mainly soft and connective tissues, with
most advanced versions being intestinal31, including small
intestinal32 and colonoids33; cerebroids34, kidney35, liver36, uterine
endometrium37 and very recently, hair-bearing skin organoids38.
However, the repertoire is much wider (see ref. 39 for a review). In
the area of bone, an organoid model is not fully existent, with
developmental stages revolving around a spheroid morphol-
ogy39,40. This is likely because of the technical difficulty compared
to softer tissues, as the formation of bone constructs requires the
careful orchestration by progenitor cells of soft matrix deposition
followed by a significant inorganic phase, which has to develop
the correct physical alignment at the molecular level, as well as a
biologically active mineral phase.
The earliest version dates back to the year 200041 when bone-
cell-formed spheroids developed micro-crystalline mineral parti-
cles termed spicules; while most recently (2019) spheroids that
recapitulate stages of endochondral bone formation were
reported42, with also preliminary reports of irregular, fibrous bone
organoids43. In all cases, these model systems focused on a
developmental/embryological type evolution, however, no model
for a mature phenotype has been developed as of yet, which
would be essential for understanding the imbalances in patholo-
gical bone formation, which is coordinated by mature osteoblas-
tic/clastic phenotypes. We have, ourselves, recently (2017)
achieved to grow a self-organising organotypic bone system
using highly osteogenic periosteal cells, which recapitulated the
bone deposition process and matured for periods beyond one
year of culture, replicating many stages of physiological tissue and
apatite mineral phase formation44–46. These constructs were
designed to be large (at the centimetre scale), as they were
scoped for applications in regenerative medicine rather than fine-
detail developmental research. Most importantly, however, this
was a static model with a longitudinal morphology. In order to
add a further level of complexity in the microenvironment,
relating to the need of applying mechanical over/under-stimula-
tion as a key culture condition, a smaller scale system was
required, that could be inserted into various perfused bioreactor
systems currently available. Thus, we have now adapted aspects of
our previous technology at the micron scale, to develop a micro-
organ prototype of bone that can increase complexity beyond the
spheroid stage. We present here the development of this organoid
prototype developed solely with primary human bone effector
cells, which becomes anatomically relevant and suitable in its
properties to be inserted into a free-falling, analogue microgravity
reactor for the study of degenerative effects induced by low-shear
mechanical stimulation. This manuscript presents results from the
three stages of organoid development, from cultivation as a
complete bone remodelling unit to encapsulation into a
physiological matrix and culture in a mechanically altered
environment. We show that the model can function as a complete




Despite their inert appearance, bones are responsible for more
than providing a framework for mechanical support. They are
continuously remodelled proportionally to the mechanical
needs47 and in the absence of mechanical stimulation they will
shift towards catabolic homeostatic mechanisms to address only
the limited amounts of stress they experience. They are also an
endocrine organ that fulfils a panoply of vital functions, including
providing a source of calcium and phosphate to the rest of the
systems and maintaining homeostasis of these elements in the
bloodstream under the control of the parathyroid hormone (PTH).
New lines of research showed that its matrix also provides a
supply of growth factors, including insulin-like growth factors48,49,
transforming growth factors such as TGF‐β1, TGF‐β2
50 and more
Fig. 1 The development of an analogue bone system with equivalent anatomical, biophysical and biochemical characteristics. a Bone
tissue (exemplified using a C. elaphus sp. antler) is composed of a network of trabecular rods, packed together to become compact bone (left).
This tissue is heavily mineralised, composed of Calcium Phosphate (left), with little protein content (right), where sulphated content is
detected in marrow cavities. b The femoral head is adapted to withstand great mechanical loads such as the upper body weight (BW), and is
therefore composed of large amounts of trabecular bone (black box). Each trabecula is adapted at the micron level to withstand forces acting
from multiple directions. c To ensure an anatomically relevant structural base for a bone organoid, thermally treated micro-trabecular particles
from femoral heads were used (500–1000 μm). These particles present the lamellar structure (d, box) of bone and surface topography (e) that
is essential for normal cell sensing and attachment. They also have a relevant biochemical composition, comprised entirely of a calcium-
phosphate phase (Micro-XRF) (f). Traces of sulphur indicative of organic matter can be detected, however, at the limit of the detection
threshold. X-ray diffraction analysis (g) confirmed these are composed of a biologically derived phase of hydroxyapatite (red bars), the mature
bone mineral. h The micro-trabeculae are naturally highly electrostatic (left), which was exploited for insertion into liquid cell suspension
droplets (right) to generate miniaturised bone avatars. A hanging-drop culture system was used to suspend trabeculae and primary female
bone effector cells and to direct attachment onto the trabecular surface through gravitational sedimentation (h, i). These were cultured for
48 h to maximise surface colonisation and self-organisation of the cells. In the absence of bone scaffolds, osteoblasts come into direct contact
with each other to form a spheroid (j, left), whereas in the presence of a trabecula they successfully populate the surface and display
osteogenic phenotypes (right). Primary female osteoclast precursors are also able to attach individually and co-cultured with osteoblasts,
generating a complete remodelling unit (k). Their presence can be differentiated on trabeculae as osteoblastic nuclei are larger than
osteoclastic ones. Scale bars as indicated.
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recently the hormone osteocalcin thought to regulate distant
functions such as glucose homeostasis, adiposity51 and stress
response30. Thus, the simultaneous physiological processes
undertaken by bone make it very difficult to maintain their health
and restore their normal composition. This is because both
mechanical loading and the hormone-controlled release of ions to
the body continuously require these elements. Therefore, the
ionic balance can be quickly disrupted, as seen in numerous
pathological states. As such, a system that can provide both
conditions would be a step forward in the development process.
In this context, the present work focused on developing a method
to generate a micron-scale trabecular construct that is biochemi-
cally relevant and sufficiently light to be inserted into an analogue
microgravity environment, where bone turnover events can be
detected while placed under an altered mechanical environment.
Design considerations
The architecture of trabecular bone (Fig. 1a), especially at sites
such as the femoral head (panel b) is optimised to match strength
and stiffness to minimal weight. The mature tissue architecture is
thought not to be fully pre-determined genetically, but gained
also through bone cell activity, which receive mechanical
information and influence this adaptation of form52. The use of
this substrate was therefore essential to initiate a mature
trabecular organoid system and to provide the local cues, required
for cell recognition and attachment. Micron-scale trabecular
particles (500–1000 μm) derived from femoral heads of xeno-
geneic sources (bovine femurs due to their anatomical similarity to
human bone) were chosen as the base of this system to ensure
anatomical-region osseous relevance (panel c). These types of
particles are thermally treated and designed for human craniofa-
cial, oncological, and other skeletal reconstruction, where, once
implanted, they can integrate with the native tissue over time53.
For this work, these were ideal anatomically, as they presented the
lamellar structure (panel d) encountered in trabecular bone, as
well as the surface nano-topography (panel e) required for cell
detection and native behaviour. These biologically derived micro-
trabeculae are composed entirely of bone mineral, made of
calcium phosphate (Fig. 1f and Supplementary Fig. 1) and thus
essential for simulating the inorganic component of this organ,
while allowing a new, organic phase to form. Importantly, unlike
other models, this mineral is biological hydroxyapatite (panel g),
with a 44.3% crystalline structure and a 55.7% amorphous phase,
stabilised into a hexagonal structure, as determined through X-ray
diffraction analysis. This high crystallinity is desirable as the rate of
hydroxyapatite resorption by osteoclasts is dependent upon this
physical property54 and as such, it is important for the generation
of a relevant bone loss model and resorption rate, which can be
similar to the in vivo context. While other synthetic laboratory-
manufactured ceramic structures could be trialled, their absorp-
tion rate would need to be optimised to ensure they maintain
their volumetric stability and do not degrade very rapidly under
osteoclastic activity.
From an animal model replacement/reduction perspective, a
technical advantage of these substrates is that they are generally
sourced from tissue waste from other industries and in addition,
minimal trabecular tissue (1–2 cm3) is required to generate a
significant number of micro-trabeculae (in the order of hundreds).
Generation of a trabecular organoid prototype using human
cells
The micro-trabeculae are hydrophilic and naturally highly electro-
static (Fig. 1h) and as such can be contained within liquid droplets
as small as 10 microlitres (panel i), which makes them ideal for
insertion into a hanging-drop culture system (panel h), commonly
used as an efficient, cost-effective method for generating
spheroids55. An important feature of this technique is that, when
used with multiple cell phenotypes, these can self-organise into
cortical and central configurations, in a surface-tension directed
manner56. These cellular kinetics were exploited in this work for
directing attachment of human bone cells, in individual and mixed
forms. These cells aggregate, under the action of gravity, on the
surface of the micro-trabeculae after being allowed to sediment
for a period of 48 h to maximise self-organisation, attachment and
cell-cell contact. Bone forming human osteoblasts, when cultured
using the traditional method are able to form spheroids (panel j,
left), whereas when the micro-trabecular component is added,
they are able to colonise the surface and express more relevant
phenotypes (panel j, right). The system allows the attachment of
both human osteoblasts and osteoclasts, the latter as either
mature and pre-osteoclastic monocytes; as well as a combination
of the two cell types (panel k). Examples from each category are
shown in Fig. 1k following 48 h inside their respective droplets.
Cytodifferentiation in organoids and mimicry of tissue
functions
Bone remodelling takes place under the action of a carefully
orchestrated and synchronised feedback system, involving three
types of bone effector cells, originating from different lineages:
the mesenchymal-derived, matrix secreting osteoblasts, their
mature phenotype (osteocytes) involved in mechanosensing and
maintenance57, and non-native pre-osteoclasts originating from
hematopoietic lines, which migrate as monocytes to the site as
required, where they differentiate near or at the bone surface
and undertake a highly destructive bone resorption activity58.
The balance between resorption-deposition is disrupted in
osteopenia/osteoporosis and it has become clear over the
recent years that it is not the isolated effect of one cell type,
but the altered response of the entire unit, which leads to a
reduction in bone mass59. This became very evident particularly
following space exploration missions60, where severe losses of
bone mass were observed at an accelerated rate compared to
osteoporotic patients, and while osteoblasts showed diminished
activity61, osteoclastogenesis was significantly increased62. Simi-
larly, using the hindlimb immobilisation methods in rodents
discussed above, a rapid increase in bone resorption was
detected as early as 3 days63, while some studies reported a
surge in osteoclast numbers per millimetre of bone surface as
early as 30 h64. On a technical level, these rapid events highlight
the need for a model that can capture the early cellular events in
such a narrow time window.
Therefore, to understand imbalances in the signalling and
communication activity in an in vitro/ex vivo model, these cells
ought to be used together in a system, which can ultimately be
subjected to altered mechanical forces. Optimisation was per-
formed using individual and mixed-cell constructs and an
osteoblast-osteoclast system represented the final set-up to
generate a complete remodelling unit that could recapitulate
the cell-cell and cell-surface-cell interactions without direct
contact of the two populations as with other juxtacrine models.
This compatibility has been previously verified by vast amounts of
research using aggregates of osteoblasts and osteoclasts, as lumps
or separated by a physical barrier on macroscopic matrices (see
refs. 65 and 66 for extensive reviews).
At this level, there were further design considerations such as
the ratio of osteoblasts to osteoclasts in our mixed model, due to
the significantly larger size of the latter, as well as due to number
of cells that could colonise the surface, calculated based on
previous models34, as well as the in vitro surface correspondence.
To simulate the bone multicellular unit, we chose this ratio as
1:2–3.5 osteoclast:osteoblast, which fits with previous compat-
ibility ratios reported as most successful for this combination of
cell types67,68. We have therefore used mixed culture media at a
ratio directly proportional to that of cells used, to deliver a
A. Iordachescu et al.
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controlled mixture of essential growth and differentiation factors
to these constructs, including pro-osteoblastic, osteoclastic and
osteocytic. Supplementary Fig. 2 provides a detailed summary of
the experimental set-up, the supplementation regime and
predicted cellular differentiation in every cell category. The ratio
of osteoblast to osteoclasts could be adjusted in future studies to
reflect different stages of the normal or clinical context.
Simulation of osteoclastic function
As mentioned above, osteoclasts play a key role in pathological
bone loss, which structurally manifests an excessive form of their
normal physiological function. Female patient-derived, primary
monocyte precursors (Fig. 2a), which had undergone tartrate-
resistant acid phosphatase (TRAP) and osteolysis validation as a
population, were cultured and differentiated through conditioning
with the receptor activator of NF-κB ligand/RANK Ligand (RANKL/
TNFSF11), as well as the macrophage-colony stimulating factor (M-
CSF). These paracrine factors native to osteoblasts and osteocytes
are both necessary and sufficient for osteoclastogenesis and can
stimulate immunological precursors in our system to maximally
differentiate in a time frame covering up to 5 days (panel b).
Following maximal attachment (approximately day 2), these cells
merge into very large, multi-nucleated structures, are mobile and
contain a typical ruffled border (panel c). The initial organoid
development was originally conducted with these matured
osteoclasts for concept proofing, which was then simplified for
use with osteoclastic progenitors, for both technical and design
advantages, as they were easier to isolate, quantify and to
simulate the migration and differentiation process at the site
during the inversed drop stages. When applied to the micro-
trabeculae as precursors, these cells mature into polykaryons and
agglomerate into large structures (panel d, left and right). In terms
of activity, at the interface with the micro-trabeculae, following
8 days of total culture, we were able to detect contact sites
containing a co-localisation of the cytoskeletal proteins actin and
β-tubulin (panel e, top and bottom). This is important as sites of
cortical actin and tubulin localisation are part of essential
podosome belt-like structures in osteoclasts, which are critical
for resorption and sealing the attachment point in order for H−
and Cl− ions to be transported through the ruffled membrane for
dissolving the mineral phase69. The ability to detect such fine
details in the system displays great promise for applications in
understanding more native behaviours of osteoclasts and we have
already started to look at the spatial localisation and chemical
nature of chlorine on the surface, which so far appears to be
independent of a common sodium salt-type association.
When constructs were cultured for 2 weeks in a test experiment,
we were able to observe perforative resorptive sites on the
trabeculae (Fig. 2f, g), which were the subject of investigation of
additional work (Figs. 4 and 5).
Simulation of (concomitant) osteoblast function and matrix
initiation
Female patient-derived osteoblasts were cultured in basal
medium supplemented with steroidal and pro-mineralisation
supplements (β-Glycerophosphate) to induce more native
specialisations. When cultured for 14 days in control medium,
these cells maintain a mesenchymal phenotype, whereas with
osteogenic supplementation, they maximally transition to a
highly dendritic morphology, and are also densely intercon-
nected, suggesting a pre-osteocytic phenotype (Fig. 3a). Further
morphologies indicating the ability to form mature osteocytes
are also demonstrated in Supplementary Fig. 3. When cultured
on micro-trabecula, they are able to develop identical dendritic
connections (panel b, c1–3), and some highly stellate looking
cells are seen embedded in new matrix formed by cells inside
the cavities of the trabeculae (panel b, c1), which are structures
of similar architecture and porosity as found in bone. At the
surface of constructs, the projections can become extensive
following 7 days of culture and contain the cytoskeletal protein
β-tubulin, as well as actin (panel d). From an anatomical
perspective, these structures are essential, as osteocytic den-
drites are key mechanosmes57,70, with absence resulting in
resistance to unloading bone loss71. Secondly, these projections
are the likely precursor of greater, more evolved structures
discussed later in Figs. 6 and 7. Lastly, the achievement of several
phenotypes is desirable for simulating a complete remodelling
unit, and the morphologies of cells from all variations, including
mixed phenotypes is presented in Supplementary Fig. 4. For
comparison, constructs that were formed without micro-
trabeculae using the inversed drop and subsequently cultured
for 7 days inside a rotary bioreactor in preparation for the final
stage, develop from a spheroid (Fig. 1j) into a lobular embryoid-
type morphology (Fig. 3e). While interesting from a develop-
mental perspective, the cellular behaviour detected in constructs
suggests the need to develop bone organoids of greater
complexity than osteospheres.
Anatomical and micro-mechanical properties of trabecular
organoids
Excessive bone resorption in pathological states leads to a
reduction in mineral content, which ultimately has a key effect
on bone micromechanics and resistance to breakage, significantly
increasing the risk of fractures72,73 and delaying healing74. In order
to investigate the degree of mineral resorption led by osteoclasts
in this system, organoids were developed with individual and
mixed populations of cells as described above. The surface of
micro-trabecula was imaged at high-resolution to detect the
results of cell activity following 8 days of total static culture
(including 6 days in non-adherent conditions). While native
endogenous resorption could be observed, as expected, in control
and osteoblast trabeculae (Fig. 4a1, 2 and 3, 4, respectively)
significant resorption lacunae were identified in osteoclast-
containing constructs (panel a5, 6), including the mixed osteo-
clastic constructs (panel a7, 8). We subsequently trialled a method
to investigate whether this loss of tissue was translated into their
mechanical resistance characteristics by subjecting organoids to
compressive testing. The maximum force required to break these
constructs was used as a measure of their mechanical capabilities
and peak forces were selected based on their fracture pattern, in
some cases characterised by multiple peaks due to the non-
geometrical shape of constructs. The maximum force was chosen
as the maximal point at which the significant collapse of the
structure was achieved. Examples from each category are
illustrated in Fig. 4b. Results from this pilot study (panel b, c)
revealed that osteoclast resorption leads to a diminishment in
mechanical resistance (panel c), as osteoclast-containing orga-
noids required significantly less force to be terminally destructed
compared to similar constructs containing osteoblasts (up to
2.91 N in osteoclast, 2.11 N in mixed constructs, compared to
4.86 N in osteoblast constructs). This suggested that it was
possible to recreate pathological biomechanics to a basic degree
through the addition of human osteoclasts. At a structural level,
interesting morphological features were detected (panel d), with
the type of resorption lacunae at the surface characterised by a
reticulate patch-type, being one of two major types that have also
been encountered in trabeculae from human femoral heads
(panel e)75.
Subjecting organoids to mechanical unloading: turning a
problem on its side
In order to simulate a reduction in the gravitational force that the
trabeculae of the femoral head are normally adapted to counter-
act during an upright position or bipedal ambulation (Fig. 5a), the
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engineered organoids were inserted into a NASA-Synthecon
bioreactor to be subjected to a reduced mechanical loading state
following the initial drop culture. This microenvironment was
achievable due to their reduced size and weight reported to that
of the large (50 ml), high-aspect-ratio rotating vessels (HARVs) of
the reactor. During a 360 degrees rotation, the culture medium
inside the vessels has a laminar flow, moving as a solid mass76,
thus creating minimal shear stress on the organoids, which
assume a circular trajectory while falling vertically. During rotation
of the gravitational vector in this model system, the forces acting
on the trabecular organoids (panel b), resulting from the
gravitational force (Fg), centrifugal forces (Fc) and hydrodynamic
resistance/drag forces (Fd) balance each other, thus preventing
sedimentation (panel c) and simulating weightlessness and
mechanical unloading. The constructs and their culture media
were analysed following 6 days of culture, at a speed of 29 RPM
under these buoyancy conditions in order to try and identify any
individual or cumulative cell responses at the structural (panel
d–h) and molecular levels (panel i, j).
When the surface of organoids was analysed for osteoclastic
activity, a similar rate of resorption as seen in static conditions was
observed (Fig. 5d), with solely osteoclast and mixed osteoclast
constructs displaying new surface resorption. Interestingly, however,
the morphological appearance of these resorption pits was
significantly different compared to static controls (panel d, e), with
only longitudinally extended types of resorption lacunae identified
in these organoids, suggesting a difference in cellular kinetics
between the two conditions. This type is also the second major style
of resorption lacuna identified in trabecula of human femoral heads
(panel f)75 and a schematic comparison between the two conditions
is presented in g. There is an extensive body of work that has tried
to provide correlations of these resorptions with taxonomy, age,
gender and trabecular positioning with sometimes inconclusive
results75,77. Therefore, the ability to detect such differences in
resorption patterns might constitute a promising way of utilising this
model, in a larger scale study.
It was then evaluated whether any differences could be detected
in constructs in the cell response when subjected to analogue
Fig. 2 Maturation of the human osteoclastic constructs and simulation of the specialised bone resorption activity encountered in vivo.
Human osteoclast precursor cells of monocytic origin (a) are incubated in the presence of pro-osteoclastic factors RANKL and M-CSF to
generate a population of multi-nucleated osteoclasts, which display the ruffled morphology indicative of their active phenotype (c, black
arrow). The fusion of monocytes into polykaryons can be observed in constructs as well after 8 days of culture (d left and zoomed, right),
where they are seen agglomerating on the surface of trabeculae. Some of the formed structures are delimited (dotted lines, arrows) to allow a
better visualisation. At the interface with the scaffold, these cell aggregates form belts (e, top and bottom) that are rich in tubulin and actin
(white arrows and dotted line). When cultured for 2 weeks, these cells can create perforative resorption patterns resembling pores and
lacunae (f, black box and g, red arrows). Scale bars as indicated.
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Fig. 3 Maturation of the human osteoblastic constructs and simulation of the osteoid producing events encountered in vivo. Human
osteoblastic cells cultured in non-osteogenic (control) medium for 14 days (a) display an unchanged osteoblastic phenotype, whereas cells
cultured in osteogenic medium for this period display a highly dendritic phenotype within an interconnected network, indicative of an
osteocytic phenotype (b). Constructs seeded with cells and cultured on non-adherent surfaces for 7 days are able to recapitulate in vivo
events such as osteoid production. New matrix is produced, which can be morphologically distinguished from the compact bone structure
(b, left, white arrows). Cavities within trabeculae are used as a sites where new matrix formation takes place (b, right), and dendritic cells are
seen embedded within this matrix (c, 1). The surface of constructs is also a site of osteoblastic-osteocytic activity, with large projections
extending across the trabeculae (c, 2, 3). In addition, communication and aggregates (red arrow) can be observed at the surface, which are
rich in tubulin and actin (d). e In contrast, constructs that were cultured in the absence of trabecula, including 7 days inside a perfused
rotating vessel, develop a lobular embryoid-type morphology. Scale bars as indicated.
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Fig. 4 Simulating bone loss in constructs and the effects on local mechanics. Resorption of the bone surface was investigated on trabeculae
from different cell-seeded groups after 8 days of culture to detect the manifestations in each type of condition. Cell-free constructs and those
that were cultured with osteoblasts show only signs of endogenous resorption, originating from the native bone tissue (a-1,2 and 3,4,
respectively). Osteoclast-cultured constructs show a significant pattern of resorption (a-5, 6), which was observed in mixed constructs as well
(a-7, 8), developed with both osteoblastic and osteoclastic cells. Dark boxes= areas of no resorption; red boxes= areas of resorption.
The mechanical properties of these groups were investigated by subjecting the cultured constructs to compressive forces and observing the
fracture patterns, related to their trabecular distribution (b), and changes in maximum force required to collapse the structure, a feature
related to their integrity (c). The values selected for comparison, for which representative examples are presented in b with orange arrows,
were chosen as the maximum compressive force that can generate the ultimate structural failure. The least-resistant organoids were those
that contained mixed osteoblasts-osteoclasts and osteoclasts alone (**p= 0.01 and *p= 0.03, respectively, n= 3), which required significantly
less force to reach terminal failure. Data is presented as mean ± SD. The resorptive patterns encountered in mixed constructs simulating a
whole remodelling unit (d) were reticulate in appearance, similar to those encountered in human trabecular bone from femoral heads. Figure
e is taken from Gentzsch et al.75 by permission from Springer Nature. Scale bars as indicated.
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microgravity. In a pilot study, the differential expression of factors
indicative of bone remodelling (Sclerostin, RANKL), endocrine
activity (Parathyroid hormone receptor 1) and mechanical sensing
(Connexin 43) across groups was investigated (Fig 5i, j). This was
performed on extracts from cell membranes that were pelleted
through centrifugation (panel i) or immuno-isolated from the liquid
phase (panel j) of the mass of culture medium in which the
constructs were suspended, to obtain a quick picture of key
secretome and receptor activities.
To break down some of these proteins from complexes with
other integral membrane proteins that are commonly found in
cellular composition, gel electrophoresis was conducted with or
without antibody recognition using western Blotting to detect
their presence either as monomers, dimers (as expected in
biological form) or associated with larger proteins.
Using both techniques, large protein complexes were detected
in all cases within the molecular range of 60–70 kDa, which
contain an association of the target protein, native cell and
A. Iordachescu et al.
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medium proteins (Fig. 5j, right black rectangles). When these
regions were probed with antibodies during western blotting
(panel i), or the protein was immuno-selected from the total
sample using magnetic immuno-isolation (panel j) several
differences could be detected across the different cell groups.
Sclerostin (SOST), a Wnt/β-catenin signalling antagonist
involved in both osteocyte and osteoclast function, and which
appeared as a dimer when ran in pure form (Fig. 5i, first panel),
was detected in osteoblastic samples, but also interestingly, in
osteoclast and mixed osteoblastic-osteoclastic samples. The
detection of Sclerostin in osteoblastic constructs suggests that,
as noticed morphologically as well, some of the cells have
matured into an osteocytic phenotype, as this protein is a
signature molecule for the terminally differentiated bone cells78,79.
Its presence in osteoclastic samples is also interesting. While this
protein is also likely present in the osteoclastic culture medium (as
indicated by the mixed control medium, which contains this
component), as it is supplemented with a cocktail of native
osteoblastic additive factors, further, pronounced bands can be
detected in the osteoclast-containing groups, suggesting a
different expression pattern of this protein in these samples. This
was also supported by the immuno-purified samples, which
demonstrated a similar expression pattern across samples (panel j,
left and right panels). This is of particular importance as Sclerostin
is thought to be an inhibitor of bone formation through osteocytic
suppression of osteoblastic function, however, similarly to this
study, more recent research has shown that osteoclasts of aging
mice express Sclerostin themselves, which reduces mineralisation
through that direct route80. It had also been previously localised in
osteoclasts in both intramembranous and endochondral bones81
and it was recently shown that osteoclasts can downregulate
Sclerostin expression in osteocytes in trabecular bone82. These
results further highlight the need for a model that can capture
these temporal events, due to the multitude of stages involved in
the signalling process between osteoblast-clast-cytes.
While bone mass is negatively regulated through an anti-
anabolic effect of osteocytes on osteoblasts via Sclerostin
secretion, catabolic actions of osteocytes can take place, via
recruitment of osteoclasts through secretion and up-regulation of
the TNF-related cytokine RANKL, which activates the RANK
receptor on the surface of hematopoietic precursor cells58,83.
Recent studies also suggested that osteocytes, not osteoblasts or
lining cells are the major source of this protein84. RANKL (Fig. 5i,
second panel), was a necessary exogenous factor in this system in
order to control the timing of osteoclast maturation. When the
levels were compared across different groups, we discovered that
this protein was not expressed in osteoblast constructs in the
absence of osteoclasts. Mixed and osteoclast constructs do
contain higher levels and further bands of this protein compared
to controls. RANKL was also detected in concentrated medium
samples, where it is similarly present in all but osteoblast samples
(panel j, left and right). As the osteoblast constructs contain some
of the initial osteoblastic population as well as many transitioning
osteocytes, as indicated by the presence of sclerostin and their
dendritic phenotype, these findings suggest that the presence of
osteoclasts or their precursors in the culture is necessary to induce
the expression of this factor, which is also supported by the fact
that direct cell-to-cell contact with the RANKL expressing cells is
known to be required for osteoclast activation85. Therefore, the
interplay between the sclerostin-mediated bone inhibition and
RANKL expression is something that could be investigated in
future studies using this system.
Calcium homeostasis and bone remodelling are also controlled
through the action of the Parathyroid hormone (PTH), which has
both anabolic and catabolic roles on the cells and bone tissue,
stimulating both bone formation and resorption86. Interestingly, the
receptor involved in this signalling cascade and which has an
endocrine role, the Parathyroid Hormone 1 Receptor (PTHR1) (Fig. 5i,
third panel), is only expressed in osteoclast-containing constructs.
This is interesting firstly because the PTH-mediated homeostasis
route is known to be an inhibitor of sclerostin expression87 and
therefore, the absence of this receptor in osteoblast constructs
appears to match the presence of sclerostin. Secondly, because the
presence of this receptor in osteoclasts has only become evident
recently88, first in the bone tissue of deer antlers (Fig. 1a), which
similarly to trabecular bone, has a high turnover/remodelling rate.
There, the PTH related peptide (PTHrP) is involved in osteoclasto-
genesis in a RANKL-independent pathway, which suggested that
osteoclasts expressing the receptor can be directly stimulated
independently of RANKL.
The gap junction protein Connexin 43 (CX43), was detected
only in osteoclastic samples, but not in osteoblastic-osteocytic
constructs (Fig. 5i, fourth panel). This is interesting because the
hemichannels that this protein forms, especially on dendrites, only
open with mechanical stimulation in response to fluid flow shear
stress89,90, which is greatly reduced in this system. This suggests
that the anabolic effects of mechanical loading through the CX43
portals could be blocked in this system. In contrast, in osteoclasts,
high expression was expected as gap-junctional CX43 plays a
functional role in these cells, being essential in multinucleation
and fusion into mature osteoclasts91, a process observed in great
detail in these constructs (Fig. 2).
Altogether, these results demonstrate a central role of all bone
cell types in the early bone signalling events. It was therefore
concluded that the most representative organoid conformation
Fig. 5 Changes in cell resorption observed with exposure to simulated microgravity. a To simulate a reduction in the force of gravity that
the femoral head trabeculae are normally adapted to resist, particularly when upright (left), organoids were placed either in static, typical
culture conditions, where they experience the normal gravitational pull, or in dynamic, rotational conditions, inside a NASA-synthecon reactor
vessel, where a laminar movement of the culture medium suspends constructs in a state of orbital buoyancy (right). During this culture model,
the forces acting on the trabecular organoids, resulting from the gravitational force (Fg), centrifugal forces (Fc) and hydrodynamic drag forces
(Fd) (b) balance each other during each orbital revolution (c), thus preventing sedimentation and simulating weightlessness. Following 6 days
of culture under these conditions, resorption induced by cells can be observed in osteoclastic and osteoblastic-osteoclastic constructs (d, red
arrows and box), which appears longitudinally extended in morphology (e). This resorption pattern resembles a second class of lacunae
encountered in trabecular bone from human femoral heads (f) and is different structurally from the type encountered in constructs cultured
under static conditions (g, h). Extracts from the incubation medium of constructs subjected to simulated microgravity were taken as pellets (i),
or immuno-purified from liquid phase (j). In both cases, large protein complexes were detected between 60 and 70 kDa, containing an
association of the target protein, native cell and medium proteins (j right, black rectangles). These regions were probed with antibodies
during western blotting (i), or the protein was immuno-selected using magnetic isolation (j, left). The protein Sclerostin (i) was detected in
osteoblastic samples, but additionally in osteoclast and mixed samples/medium. This pattern was also observed in concentrated medium
samples (j, left—immuno-selected samples and right—all samples including medium). RANKL (i) was not expressed in osteoblast constructs,
in the absence of osteoclasts. RANKL was also detected in concentrated medium samples, in all but osteoblast samples (j). The endocrine
protein PTHR1 and integrin CX43 (i) were only detected in osteoclastic constructs. Figure f is taken from Gentzsch et al.75 by permission from
Springer Nature. Scale bars as indicated.
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was, as predicted, the mixed osteoblast-clast variation, which was
used further in development.
Recreating the physiological and pathological environments
The next stage of development involved providing trabecular
organoids with an optimal remodelling-permissive environment
by adding missing instructional cues in terms of structure and
chemistry, thus leading towards a multi-level system with
increased complexity and relevance.
Therefore, mixed osteoblast-osteoclasts constructs were encap-
sulated into human blood clot-like-fibrin domes reconstituted
from human fibrinogen and thrombin, in order to generate
proliferation in an endogenous environment that the cells are
naturally programmed to respond to. In a parallel experiment,
these constructs were embedded for comparison in xenogeneic
Matrigel®, the current gold standard for organoid proliferation.
Because of the mixed phenotypic nature of the constructs and
supplementation conditions, the latter were gradually introduced
in this system over a period of 10 days, during which they were
transferred, as with previous studies34 from a spheroid system to a
non-adhesive two-dimensional (2D) vessel for 8 days, before being
encapsulated into fibrin for a further 8 days. A schematic of the
timeline of events is provided in Supplementary Fig. 5.
When imaged at day 19, the morphologies of proliferating
masses were observed to be completely different in the
anatomical organoids (Fig. 6a) compared to tumorigenic Matrigel®
organoids (panel b). Constructs seeded into fibrin develop a
significant projection-led expansion into the surrounding matrix
(panel a). In contrast, Matrigel® inserted organoids formed packed
masses of cells displaying a lobular growth (panel b).
The chemical nature of projections was probed using Micro
X-ray fluorescence mapping at day 19 of culture, to allow for an
immediate, non-destructive spatial localisation of mineral and
matrix components, with different elements coding for distinct
anatomical structures (Fig. 6c). As Phosphorus (P) is an element
present in both the mineral and cellular component, Potassium
(K), one of the most abundant intracellular ions, was comple-
mentarily used to spatially distinguish the cells from the matrix
and mineral component. While Calcium (Ca) was ubiquitous in this
system, we observed a significant phosphorus-led front emerging
from trabecular constructs into the fibrin matrix and co-localised
with these projections. Some of these deposits were localised in
the vicinity of K+ containing projections, in areas also rich in
Sulphur (S), used as an indication of matrix protein content.
Altogether, these results suggested that the projections were
involved in a type of mineralised matrix deposition at sites away
from the main structure. This was also probed using Micro-
Computed Tomography (panel d, e), which allowed the detection
of discrete, pocket-like deposits of lower density material forming
in lieu of the original fibrin content.
Despite their atypical morphologies, masses of proliferating
cells extending into Matrigel® also develop a phosphate and
sulphur-rich matrix (Supplementary Fig. 6). Therefore, the Matri-
gel® model might, nevertheless, be able to simulate an orthotopic
tissue environment in vitro, which could recapitulate aspects of
the early histotype arising during a cancerous development.
These results also indicate the need for efforts to be directed
towards developing organoids using more endogenous matrices
that have a better characterised, homogenous biochemistry and
clinical applicability, something that has been increasingly
recognised and approached92 recently.
Unlike blood-derived fibrin, Matrigel® is a highly bioactive,
basement membrane derived from the Engelbreth‐Holm‐Swarm
mouse sarcoma, containing an abundance of collagens, laminins,
glycosylated molecules and basement membrane components93.
Thus, a large basis for their success in generating relevant organoids
is therefore due to this rich template, which molecularly directs an
invasive cellular proliferation in a tumorigenic environment. Within
the bone organoid field, this is not always desired, especially as the
role of certain compounds in vivo are not fully characterised.
Certain laminins, for example, produced by osteoblasts, can have a
role in supressing osteoclastogenesis in bone94.
Fibrin, potentially due to its physiological similarities to those of
a real blood clot, has been particularly useful recently in directing
embedded cells to form relevant anatomical networks, with recent
reports of spherical fibrin beads supporting vascular morphogen-
esis within95, some primitive versions that we were ourselves able
to generate using these cells in fibrin in our previous, adapted
organotypic bone model44.
A further advantage, exploited by other authors as well, is that
these fibrin structures can be fused (Fig. 6d) or embedded into
further fibrin matrices, making it possible to model complex
geometrical structures. From a clinical application perspective, they
have also been for many years a delivery vehicle for a wide range of
orthopaedic reconstructive procedures96 and in this respect, this
model represents a preclinical advancement as it comprises a
reconstructive bone element, a surgical haemostatic agent, as well
as primary gender-matched patient cells, which could be used for
personalised and regenerative medicine applications.
From bone loss to bone remodelling and fracture repair
Following encapsulation in human fibrin, organoids were inserted
in the last stage of development into the perfused, analogue
microgravity state for 5 days in order to capture the early cellular
events induced by unloading, while encapsulated in a tissue-like
unit (Fig. 7). Because of this further level of complexity, a second
condition was set-up to ensure that any differences recorded (e.g.,
the potential presence/absence of formations within fibrin) could
be accounted for from a gravitational perspective, rather than any
hydrodynamic conditions in the reactor. Therefore, constructs were
suspended, additionally to the traditional free-fall orbital path along
the vertical axis, into a second dynamic condition, revolving within
a horizontal plane (Supplementary Fig. 7), which was termed
‘Normal’ Gravity, only to reflect the more traditional distribution of
vectors in this system. This parallel system was set-up to ensure that
even during short periods of culture, a similar level of perfusion was
tested for comparison, in order to check whether any arising
differences would be induced by the reactor conditions themselves
at this stage. While these effects would not necessarily become
evident during shorter time frames, they would need to be a
consideration prior to larger, scaled up versions due to the
distribution of liquid, as well as before longer cultures.
Following 5 days of orbital trajectory suspension inside the
vessels of both conditions, several remarkable features were noticed
in constructs. Firstly, areas of dispersed mineral particles resembling
bone loss could be observed in the vicinity of constructs and
trapped inside the clot-like matrix (Fig. 7a, red boxes). Secondly,
significant tubular-like projections can be seen emerging from the
mineral interface in organoids (panel a, top and bottom), which, in
most cases, extend to the millimetre scale across all axes (panel b).
Several additional features were observed in both dynamic
conditions. Firstly, masses of mineral can be seen forming from
the initial structure, in some cases in a tubular form (panel a, top
panel). Secondly, mineral fragments can be seen being transported
along these tubules to sites distant from the main structure (panel
a, top and bottom). Lastly, large particles of bone mineral, likely
originating from the initial structure can be observed trapped
within networks formed at the surface of constructs (bottom panel).
When these structures were chemically probed at high resolution
using Micro-X-Ray Fluorescence, the tubular projections were
shown to be composed of protein content co-localised with
mineral ions along their lengths (panel c, d). Large spatial maps
showed intricate networks of early mineralised matrix
structures led by cells and extending from the main organoid
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structure in both conditions (panel e). To illustrate differences that
can be assessed in these constructs, two examples were provided
for morphological comparison at an individual construct level in
Fig. 7e. These include a construct in the normal gravity condition
(top) that contains a higher number of projections compared to a
simulated microgravity-cultured construct (bottom), which con-
tains a main tubular structure forming into the matrix, but which
displays many possible emerging structures, based on the
distribution of potassium (K), in network-like arrangements
surrounding the initial structure.
Based on these initial observations on the morphometric
characteristics of these tubules forming in constructs, long-term
studies could search for differences in the number of projections
and their comparative lengths. This could provide further answers
regarding the differences in the bone remodelling process
between simulated microgravity and the normal context, espe-
cially in cytoskeletal organisation, which has been reported to
change in microgravity97,98.
At the molecular level, a non-quantitative assessment of the
protein markers discussed previously, showed the expression of
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Sclerostin and RANKL in both conditions as noticed previously in
multicellular constructs, while in comparison, the expression of the
mechanosensing-relevant protein CX43 was less pronounced in
both groups, suggesting adaptive changes at different signalling
levels (Fig. 7f). Interestingly, the parathyroid hormone receptor
protein (PTHR1) was detected in the normal gravity group,
however, the specific signal was not categorical in the simulated
microgravity group. Further studies could test this expression at
different time points to detect any differences in the regulatory
pathway controlling the bone remodelling process (either
anabolic or catabolic) between the two contexts, especially in
relation to sclerostin and RANKL expression.
We also determined during pilot work, where constructs were
embedded into human fibrin after being exposed to simulated
microgravity, that distant spots such as the ones observed in Fig.
7e can advance into more significant structures (Fig. 8a–c) over
several weeks, acting as nucleation points for new mineralised
matrix formation and generating ‘mini-trabecular’ structures. We
have now developed ways to quantify this bone formation
process as a ratio of the new mineral formed in the organoid to
that of the initial construct, calculated directly from these maps
using Micro-XRF (panel c), which will allow more quantitative
evaluation of bone formation during long-term cultures or larger
scale use. As an example, osteoblastic constructs that were either
cultured under static conditions (panel d, top) or simulated
microgravity (bottom) for 7 days, followed by culture in fibrin for
3 weeks, were assessed for matrix deposition using this semi-
quantitative method. A rate of remodelling can be estimated by
normalising the average elemental content of the organoid to that
of the initial trabecular construct from the acquired spatial maps
for each element. This could demonstrate differences at the
matrix-mineral level, where potentially larger deposits are notice-
able in the simulated microgravity group (panel d) compared to
static, which is translated in the numerical form (panel e).
Alternatively, regional comparisons can be conducted within
and across samples, provided that the selected region is identical
in size (panel f, left and right). This type of numerical extrapolation
can also be performed using normal imaging software on an
intensity basis, from colorimetric or fluorescence labelled con-
structs. If available, one of the most rapid and quantitative
methods to assess the degree of change in constructs is using
micro-computed tomography (which is also described in Fig. 8g),
as this technique, which was previously used44 to look for mineral
deposition in heterogeneous constructs, facilitates the selection
and morphometric analysis of specific matrices in composite
systems based on their density. For example, the highest density
mineral (in this context, the initial trabecula), can be separated
from lower density mineral that is newly forming, as well as the
lowest density material in the system, which is the initial fibrin
scaffold. In this way, the mineral volume (mm3) can be obtained
and further information on mineral mass could potentially be
extracted. Moreover, the same function or function sets can be
applied at different time points.
Finally, as the construct diameter matches that of the wells of a
96-slot assay plate, for industrial or large-scale applications, the
constructs could be used with more automated (high-throughput)
systems in order to test the effects of drugs and other agents
during genetic or pharmacological assays (Fig. 8g). Following
incubation with the compounds of interest, the change in bone
formation can be assessed either by recovering these organoids
and analysing them individually or as a mass using Micro-CT as
discussed above, or more commonly, directly within the wells
through colorimetric or fluorescent detection. Many recent
fluorometric detection systems are also able to measure regional
intensities within a well, which may provide further levels of
information on spatial distribution of new components. Depend-
ing on the features available on the automated system, further
tests can be applied, such as illumination with polarised light,
which could generate different results at different time points
depending on the degree of formation of new matrix and
therefore the orientation of mineral crystallites as the tissue is
maturing.
Overall, this organoid model can provide a window into the
early, fine-scale mechanistic events during bone formation. The
events recorded in these organoid prototypes mirror both
resorption/mineral loss events and the subsequent osteo-
proliferation and mineral deposition and therefore, it is likely that
constructs recapitulate several steps involved in the bone
remodelling process, which can be tuned in the experimental
design to simulate both the normal and abnormal physiology.
Nonetheless, the pathological mechanisms in all bone-loss
involving conditions, while complex, are ultimately mediated
through effects on the bone remodelling cycle and therefore, the
restoration of tissue and fractures recapitulates many of the
ontological events of embryonic skeletal development. Therefore,
the behaviour of cells seen when encapsulating organoids in the
blood clot-like fibrin matrices reflect a variety of important
previous theories regarding bone remodelling and observations
regarding cell behaviours inside haematomas. Indeed, it is now
known from mouse models of fracture healing that both events
are tightly controlled even at a transcriptional level, as a third of
the genes homologous to embryonic stem cells are also involved
in fracture healing, that the homeotic genes involved in skeletal
development are also induced during repair and that primary
morphogenetic pathways, including BMPs, Wnts and FGFs are
concurrently expressed during development and fracture repair99.
Fig. 6 Encapsulation of trabecular organoids into biochemical microenvironments that can generate bone physiological or pathological
prototypes. a and b present two examples each of constructs that were encapsulated into a physiological (human fibrin) and tumorigenic
environment (Matrigel®). Constructs that were encapsulated in fibrin (day 19) create extensive projections (orange arrows) into the
surrounding environment (a-top), which stretch from multiple points on the surface (middle). These constructs are heavily populated with
cells (bottom). Constructs embedded in Matrigel® (day 16) also display highly proliferative cells, however, the pattern and morphology of these
cells is more representative of a tumouroid, as they are densely packed into atypical phenotypes (pink arrows). These lobular proliferative
regions have been delimited with a dotted white line for easier visualisation. c The chemical composition of fibrin-embedded constructs and
nature of projections was probed using X-ray fluorescence mapping to allow for spatial detection of new features, with different elements
coding for distinct anatomical structures. The projections emerging from the construct surface (grey arrows and black arrows) contain a large
amount of Phosphorus (P). Calcium (Ca) is also present in the newly forming structures. Potassium (K), an intracellular ion present in cells is
seen within these dendritic structures (pink arrows) and co-localised with the Phosphorus deposits, however, discrete deposits of P are found
on their own surrounding the K structures (green arrows). Areas rich in Sulphur (S) are also seen localised to the regions where projections
and matrix are forming (white arrows). Organoids were scanned with Micro-CT as a fused mass (d) to detect compositional gradients based on
density. Owing to the dense nature of the trabecula, organoids behave like bone tissue when subjected to X-Ray radiation and as such, display
selective attenuation at the surface (the beam hardening effect). Therefore, beam artefacts were removed and a function was applied to
remove the lower density ranges of data (e). White arrows show discrete pockets of a denser (blue) material in different constructs in the near
vicinity or emerging from the very dense (red) surface, and trapped within the lowest density (green), surrounding fibrin material. Scale bars
as indicated.
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The results also highlight that by using relevant, matched and
matured populations inside a native matrix rather than a precursor
embryonic-type line (which in this organ model is a necessity due
to the mixed origins of effector cells) it can influence more native
behaviours and structure formations compared to more develop-
mental models, which can sometimes have a stochastic develop-
ment and depend largely on self-organisation, that could result in
high phenotypic noise100.
Secondly, the use of naturally encountered matrices could
prevent the pathological transformation of the organoid into a
cancerous model as suggested by the Matrigel®-encased con-
structs, thus restructuring the microenvironment, and becoming
less representative of the physiological state.
To our knowledge, a similar human cell-based organoid model
allowing the observation of detailed morphological and resorption
events from bone tissue at the micron scale has not been
developed to date, neither a platform that can allow an extensive
chemical characterisation of these events. Several osteosphere
variations of osteoblastic-osteoclastic constructs have become
increasingly available over the years, with or without suspension
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culture for increased perfusion, and with or without physical
barriers of varying biochemistry65,66,101, thus simulating individual
aspects of pathology and cell interactions. Alternatively, explant
chips from rat bones were successfully used with similar
bioreactors for understanding some of the effects of weightless-
ness102, however, with the obvious disadvantages of relying on
animal tissue, as well as controlling any processing effects on the
cells. However, we believe that our results bring the field closer to
developing a microphysiological system of bone by providing a
simplistic, yet biochemically sufficient remodelling unit, where
mature human phenotypes can be tuned and observed in detail.
Advancing the design forward from a traditional spheroidal model
is essential to allow cells to behave in more native ways and to
generate micro-tissues ex vivo that could complement, or replace
some of the animal models that currently exist for bone loss
research.
CONCLUSIONS
We have presented here results from an early bone organoid
prototype that displays promise for studying temporal events in
bone remodelling, which may not be accessible using other
in vitro and in vivo technologies. In addition, the morphometric
features of these constructs make them compatible with a wide
range of platforms that can simulate tissue-tissue interfaces and
dynamic conditions, including organs-on-chips and thus, could
have a major role to play in the preclinical drug development
pipeline.
METHODS
Human cell selection and culture
Human osteoblasts from a female gender, Caucasian donor of an age of 32
years, were acquired from manufacturer Lonza (Lonza Walkersville Inc.,
USA). The cells were isolated from donated tissue after obtaining legal
authorisation for use in research. All culturing reagents were supplied by
this manufacturer unless stated otherwise. Cells were cultured in basal
medium containing 10% fetal bovine serum (FBS), 0.1% gentamycin
sulphate-amphotericin B (GA-1000) and 0.1% ascorbic acid. For differentia-
tion, the medium was further supplemented with hydrocortisone 21
hemisuccinate (200 nM final concentration) and β-glycerophosphate
(10mM final concentration). Hydrocortisone was chosen to induce
differentiation as part of a defined supplementation regime (OGMTM
SingleQuotsTM) from the manufacturer Lonza (Lonza Walkersville Inc., USA),
which tested and certified its use with the primary human osteoblastic
cells as leading to alkaline phosphatase positive (immunofluorescence)
and mineralisation positive (von Kossa staining) cells. Therefore, the
Hydrocortisone-β-Glycerophosphate regime was employed both to ensure
the expected differentiation and mineralisation, as well as to minimise
potential variability due to using a differentiation diet containing an
alternative steroid, e.g., dexamethasone, which is commonly used. Cells
were cultured and used at passages 3–4 to develop organoids.
A population of human osteoclast precursors from a female donor were
also acquired from manufacturer Lonza (Lonza Walkersville Inc., USA),
which were isolated following acquisition of legal authorisation for use in
research. These cells were certified as TRAP-competent using staining and
guaranteed as ≥40% or 100 TRAP positive, as well as ≥100,000 RFU
Osteoclast Precursors Differentiated cells using an OsteoLyse Assay test
(Lonza Walkersville Inc., USA). Cells were cultured in basal medium
containing 10% FBS, 1% Penicillin-Streptomycin, 1% L-Glutamine, 0.1%
rhM-CSF and 2 µg of soluble RANK Ligand. These cells were used directly
following resuspension in culture medium to remove the cryopreservation
agent or following one differentiation cycle, when they were lifted using
standard subculturing protocols.
Human trabecular organoid prototype development
Trabecular fragments (500–1000 µm) used as grafting materials for human
maxillofacial reconstruction (Cerabone®, Botiss Biomaterials, GmbH, Ger-
many), originating from the femoral heads of xenogeneic sources (New
Zealand cattle) were used as the base for organoid generation. These
fragments are thermally heated up to >1200 °C to remove the organic
component according to ISO standards DIN EN ISO 22442-1, DIN EN ISO
22442-2 and DIN EN ISO 22442-3, leaving solely a phase of hydroxyapatite
mineral in their structure.
Cells were seeded on the surface of trabeculae using an inverted drop
culture, where 10 µl drops containing the trabecular structure and a cell
suspension were incubated in an inversed manner for a period of 48 h to
direct attachment using the gravitational pull and maximise colonisation.
The drops were deposited on the inside surface of a tissue-culture
treated 60 mm petri dish, while 5 ml of phosphate buffered saline were
added to the bottom of the dish to create a humid environment/a
hydration chamber, thus preventing evaporation. Individual osteoblastic,
pre-osteoclastic and mixed populations were cultured on these scaffolds.
Mixed cells organoids were generated using a ratio of 1:2-1:3.5
osteoclast:osteoblast. Cell concentrations were adjusted prior to mixing
and were applied as 5 µl of each population to generate a 10 µl drop. In
encapsulated forms, 2500 osteoclast precursors to 5000 osteoblasts were
used (1:2), while in non-encapsulated forms 500:1250 (1:2.5) and
350:1250 (1:3.5) were used. The initial optimisation work using non-
encapsulated constructs started with a lower proportion of osteoclasts to
osteoblasts to determine a minimum amount of cells that can elicit an
effect and to observe the colonisation of the mineral surface. This
number was subsequently increased to 1:2 osteoclasts: osteoblasts in
encapsulated form.
Encapsulation of organoids
Mixed-cell organoids were individually transferred to the wells of 48-well
non-adherent culture plates (Greiner Bio-One, Austria) and their medium
was replaced every other day. Organoids were handled by aspirating using
an 1000 µl pipettor connected to tips that had ~1 cm of the tip removed
Fig. 7 From bone loss to bone remodelling and fracture repair. Mixed-cell organoids were investigated following 23 days of total culture,
including 5 days inside a simulated microgravity vessel under two rotating conditions (simulated Micro G and Normal G Dynamic). a When
imaged using brightfield microscopy, areas of significant bone loss (red squares) can be observed at various locations adjacent to the
organoid surface in both conditions. Large tubular projections (black arrows) can be observed emerging in both conditions from the original
organoid and into the surrounding fibrin matrix. Some dense mineral-tubular structures (T) are seen forming from the surface (top panel,
white dotted lines). These projections carry mineral (red arrows) to sites away from the main structure. These structures can reach ~1
millimetre, as observed in this simulated microgravity-cultured construct (b). These large projections were chemically mapped at high
resolution using Micro-X-Ray Fluorescence and were shown to contain a mixture of protein and mineral content (c, d), where the elements
Sulphur, Phosphorus and Calcium were co-localised in both conditions along the length of these tubule formations (d). e Whole maps of
constructs revealed intricate networks of mineralised matrix projections also containing cells in both conditions (coloured arrows) and
differences could be assessed morphologically. In these particular examples selected, a construct from the normal gravity condition (top)
contains a higher number of projections compared to the simulated microgravity construct (bottom), which contains a main tubular structure
forming into the matrix, but which displays many potentially emerging structures, based on the distribution of potassium (K), in networks
surrounding the initial structure. Molecularly, a non-quantitative protein assessment of constructs revealed that the Sclerostin and RANKL
presence was pronounced within each condition compared to that of the endocrine Parathyroid Hormone Receptor 1 and to the shear-
responsive Connexin 43 channels (f). The presence of PTHR1 in the modelled microgravity group was not clearly detected, however, it was
present in the normal gravity condition, which may indicate differences in the regulatory pathway controlling the bone remodelling process
between the two contexts.
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with a sterile scalpel. Following 8 days of acclimatisation into an
osteogenic environment containing 200 nM Hydrocortisone and 10mM
β-Glycerophosphate in a low-binding environment (following 10 days of
total culture), constructs were transferred into human blood clot-like fibrin
domes, generated using a previously described technique for producing
bovine fibrin44,46. Essentially, the scaffold is created using the reaction
between the (in this case human-derived) endolytic serine protease
thrombin, which selectively cleaves the Arg-Gly bonds of fibrinogen to
form fibrin. High activity thrombin from human plasma (≥1000 NIH units/
mg protein) (Sigma Aldrich–Merck KGaA, Darmstadt, Germany) was
reconstituted using 0.1% albumin from human serum (Sigma
Aldrich–Merck KGaA, Darmstadt, Germany) in 5ml F12K Nutrient Mixture
with Kaighn’s Modification (1X) (Gibco Life Technologies, Paisley, United
Kingdom) to achieve a final concentration of 200 units per ml. Fibrinogen
from human plasma (50–70% protein, ≥80% of protein clottable) (Sigma
Aldrich–Merck KGaA, Darmstadt, Germany) was reconstituted in F12K
Nutrient Mixture (1X) with Kaighn’s Modification (Gibco Life Technologies)
at a ratio of 20mg/ml. Thrombin was added to a solution containing the
cell culture medium at a ratio of 50 μl/ml. The anti-fibrinolytic agents
aminohexanoic acid (200mM) (Sigma Aldrich-Merck KGaA, Darmstadt,
Germany) and aprotinin from bovine lung (10 mg/ml) (Roche Diagnostics
GmbH, Mannheim, Germany) were added to the thrombin solution at a
A. Iordachescu et al.
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ratio of 2 μl/ml in order to reduce the degradation rate of the fibrin gel.
Each scaffold was generated by mixing a ratio of 2.5 thrombin solution:
fibrinogen as per previous methods to generate an 100 μl construct
(71.43 μl thrombin solution to 28.57 μl fibrinogen). Gels were allowed to
polymerise for 30min at 37 °C inside 96-well U-bottom tissue-culture
plates, generating dome-shaped structures. Constructs were pipetted to
the surface of polymerised clots and 100 µl of medium was provided to
each construct. Subsequently, the constructs became transiently encapsu-
lated into the structure over the following day, which is allowed by the
self-healing property of this versatile polymer and were cultured for a total
of 8 days.
In parallel, an experiment was set-up for comparison where organoids
from the same population were transferred following inversed drop culture
into Matrigel® domes. These were created using similar methods described
previously34, by pipetting into 30 µl of cold Matrigel® droplets on a sheet of
Parafilm with small 5 mm dimeter dimples, formed by pressing with a
standard sterile rayon swab (155C) (Copan Diagnostics Inc., California, USA)
against the indentations of a 10 µl pipette tip rack (Starlab, United
Kingdom). These droplets were allowed to polymerise at 37 °C and were
subsequently removed from Parafilm and transferred into osteoblastic-
osteoclastic medium and fed every other day.
Simulation of mechanical unloading conditions
In order to expose organoids to a reduced mechanical environment, a
rotating bioreactor (NASA/Synthecon Inc. Houston, Texas) was used to
subject trabecular organoids, in a direct of encapsulated form, to a state of
orbital buoyancy, experiencing minimal shear and cancelling the gravita-
tional pull. Constructs were inserted into single-use 50ml High Aspect
Ratio Vessels (HARVs) containing a large silicone membrane allowing for
enhanced gas exchange. These chambers were filled with culture media by
simultaneously operating two 10ml Luer Lock syringes connected to the
vessel valves, out of which one was used to inject the culture medium and
the second to capture the air pockets until they were completely removed.
Constructs were pipetted into these chambers using the vessel’s main port,
which was sealed prior to attachment to the rotary engine. Vessels
containing the encapsulated constructs and anchorless constructs were
rotated at 23 RPM constant. The vessels containing non-encapsulated
constructs were rotated at 29 RPM constant to achieve orbital buoyancy
and prevent sedimentation. To determine the ideal rotational speed for the
culture vessel, the dynamic behaviour of constructs was observed as the
speed was gradually increased using the tachometer on the control unit,
from 0 RPM, until the constructs achieved terminal velocity in uniform,
circular, free-falling trajectories. Rotational speeds below and higher than
the ideal value lead to similar, though inconsistent trajectories.
In non-encapsulated construct work, comparisons were performed
between the simulated microgravity condition and the equivalent, static
controls. In encapsulated constructs, due to the presence of the fibrin
matrix, a second dynamic condition was used in parallel to simulated
microgravity, where a second reactor was run horizontally and in parallel to
ensure that any potential differences obtained could be related to the
gravitational context rather than the conditions inside the reactor vessel.
Imaging of whole organoids
Cells in fixed constructs were fluorescently labelled with the phallotoxin
Phalloidin conjugated to Alexa Flor 555 for cytoskeletal labelling (Thermo
Fisher Scientific, Massachusetts, USA), diluted to a concentration of 200
units per ml (6.6 μM) and 3U were applied to each sample. The dye was
used in conjunction with the nuclear/DNA staining dye 4′,6-Diamidine-2′-
phenylindole (DAPI) (Thermo Fisher Scientific, Massachusetts, USA).
Brightfield images of live cells and organoids were captured using an
EVOS XL Core Imaging system (Invitrogen, Life Technologies, Oregon, USA).
Calcein acetoxymethyl (AM) was used to fluorescently label live cells at a
ratio of 1–2 μl/ml and was allowed to incubate with organoids for 20min
before imaging. Cellular nuclei in organoids were imaged using NucBlueTM
Live Cell stain containing Hoechst 33342 (2’-[4-ethoxyphenyl]-5-[4-methyl-
1-piperazinyl]-2,5’-bi-1H-benzimidazole) (Invitrogen, Life Technologies,
Oregon, USA). The reagent was added at a ratio of 2 drops/ml and
incubated with the cells for 15minutes before imaging as a single label or
multiplexed with additional dyes. Cellular structures in organoids (tubulin,
actin) were imaged using commercial dyes CellLight® BacMam 2.0 (Thermo
Fisher Scientific, Massachusetts, USA), containing fusion constructs of the
plasma membrane myristolyation/palmitoylation sequence from human
Lck tyrosine kinase (0.9 kD, H. sapiens) and TagRFP; and of N-terminus of
β-tubulin (49.8 kD, H. sapiens) and emGP. The reagents were incubated
with the cells at a ratio of 50 particles per cell (PPC) for 18 h at 37 °C to
allow cells to express RFP and GFP and were then imaged using an
Olympus Fluoview FV1000 confocal laser scanning microscope (Olympus,
Tokyo, Japan) equipped with a multi-line argon laser FV5-LAMAR/LAMAR-2
and a Helium-Neon Green Laser FV5-LAHEG-2/FV5-LAHEG. Images
acquired from excitation at 405/488/543 nm wavelengths were collected
in individual channels and combined using the Fluoview FV10-ASW
software, version 4.2 (Olympus, Tokyo, Japan).
Wide-field fluorescence images of encapsulated live organoids were
acquired using an EVOS fluorescence cell imaging system (M5000)
(Invitrogen, Life Technologies, Oregon, USA), capturing transmitted light
and two fluorescence channels (DAPI and GFP).
Chemical mapping using micro X-ray fluorescence
spectroscopy (micro-XRF)
A micro X-ray fluorescence (μ-XRF) system (M4 Tornado, Bruker
Instruments, Germany) was used to generate spatially resolved chemical
maps of organoids, scaffolds and bone tissue and to investigate the
formation of matrix and cellular structures within fibrin matrices by coding
for CAlcium, Phosphorus, Sulphur and Potassium, present in these
structures. The machine contains a rhodium μ-focus X-Ray tube and a
polycapillary lens, used to focus the X-Rays to a spot size of 25 μm.
Recordings were taken without prior sample processing, at room
temperature and under vacuum conditions. The X-Ray tube operated at
a voltage of 50 kV and 200/400 μA anode current. High-resolution maps
were acquired using a spot size between 4–20 μm and exposure times of
2–50ms/pixel. The same settings were used for all constructs in the same
group of investigation. Elemental maps were formed in real time by
integrating the photon counts around the emission lines of Ca (Kα), P (Kα),
S (Kα), K (Kα), generating an image where pixel intensity was proportional
to the number of X-Ray counts/s per electronvolt (eV) from each measured
point on the construct. Thus, pixel intensity increased with X-Ray counts,
Fig. 8 Evolution of constructs and potential applications of the model. a Osteoblast constructs that were previously cultured under low-
shear conditions for 7 days and subsequently seeded into fibrin matrices, are able to form micro-trabecular shaped soft structures during
3 weeks of culture and to generate nucleation points at sites far away from the initial organoid structure (red squares). This new matrix shows
a mixture of protein and inorganic content and a phosphorus-led mineralisation (b). c It is possible to quantitatively assess the degree of new
bone formation by measuring the ratios of elements from the initial construct (yellow shape) compared to the overall organoid (green shape)
to assess the degree of change. d In these examples from osteoblastic constructs that were either cultured in a static condition (top) or
simulated microgravity (bottom) for 7 days and subsequently developed in fibrin for 3 weeks, a rate of remodelling (e) could be calculated
from the acquired maps by normalising the average elemental content of the organoid to that of the initial trabecular construct. Alternatively,
in the example provided in f (left) from a previous organoid, regions of interest can be compared within or across samples, provided that the
surface area selected is constant (f, right). As shown, the differences between Area 1, containing a visibly larger amount of new matrix
compared to Area 2, can be successfully translated numerically based on the elemental content. Owing to the small diameter of organoids,
constructs can be used with more automated systems to determine the effects of various agents (g). Change can be assessed by recovering
the organoids and analysing them volumetrically (individually or as a mass) with technologies such as micro-CT, which facilitate a density-
based selection (as exemplified here using a function selecting the highest density mineral, i.e., the initial bone). Further tests can be applied,
such as illumination with polarised light, which will vary based on the orientation of crystallographic axes within the construct, linked to the
degree of new bone formation. Additional colorimetric and fluorescence-based assays specific to bone tissue can be used in conjunction.
Scale bars as indicated.
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with maximum pixel intensity normalised to the highest count rate per eV
for each element of interest, across the entire construct.
Microtomographies of constructs
A micro-computed tomography system (μCT) (SkyScan 1172, Bruker
Instruments, Germany), was used to evaluate mineralisation and matrix
formation in encapsulated organoids on a density basis. Constructs were
removed from culture medium and fixed using 4% paraformaldehyde for
1 h, thoroughly rinsed using PBS and scanned as a fused mass by placing
vertically inside a 7ml polystyrene Bijou container (Thermo Fisher
Scientific, Massachusetts, USA) on the rotating stage inside the scanner
(positions: 91.3 mm object to source and 217.11mm camera to source).
High-resolution scans were performed at ambient pressure using the cone-
beam imaging system, composed of a Hamamatsu X-Ray source with a
voltage of 80 kV and a tube current of 100 μA. The X-Ray detector
consisted of an 11Mp X-Ray camera of a 9.01 μm pixel size, generating
images of 3.79 μm pixel size. Two-dimensional cross-section slices of the
constructs were acquired using a rotation step of 0.1 degrees, with two
frames averaging per step and an exposure time of 1180ms. Acquired
images were three-dimensional (3D) reconstructed using the Bruker micro-
CT NRecon Software (v. 1.7.1.0). For removal of scanning artefacts, the
beam hardening correction was set to a value of 30% to correct for the
surface-to-depth density gradient caused by increased X-Ray attenuation
at the surface of the bone constructs. A ring artefact correction was set to a
level of 31. The smoothing parameter was adjusted to a value of 4.
Trabeculae without cells were scanned as a mass and reconstructed using
the settings described above, at 0.2 degree rotation (44.02mm object to
source distance), and an image pixel size of 1.83 μm. Transfer functions
were created in the CTVox software that allowed segmentation of the
high-density matrix components, as well as for creating colour-coded
versions of the multiple components in constructs.
Surface characterisation using scanning electron microscopy
(SEM)
Constructs were removed from culture and dried overnight at room
temperature, as preserving cells was not required for surface analysis. They
were then mounted on top of double adhesive carbon discs attached to
aluminium stages. The structures were sputter coated with either Ag or Pd
and secondary electron micrographs of the surface were acquired under
vacuum, with a beam power of 15 kV using a Hitachi TM3030Plus tabletop
SEM microscope (Hitachi, Tokyo, Japan). A selection of constructs from
these populations were used for mechanical testing at the end to ensure
correspondence between the resorption and mechanical datasets.
Mechanical testing of organoids
A Zwick/Roell Z030 universal mechanical tester was used to compare
compressive force resistance across different construct groups. Compres-
sion was conducted using a 50 kN load cell on a 30 kN frame. Organoids
were placed on the bottom plate while the top plate was accelerated at a
speed of 2 mm/min and compressed the sample until terminal failure of
the structure was achieved.
X-ray diffraction analysis
X-ray diffraction analysis (XRD) was performed on the trabecular fragments
using a D8 Advance diffractometer instrument equipped with a Cu X-ray
source (1.5418 Å) and LYNXEYE (1D mode) detector (Bruker Instruments,
Germany). Trabeculae were analysed intact and diffraction patterns were
acquired between 10–50° 2θ, with a step size of 0.02° and a step time of
0.3 s. The diffraction pattern was matched against that of biological apatite
using PDF No. 00-046-0905 from the integrated database from Interna-
tional Centre for Diffraction data.
Sample processing for molecular characterisation
To analyse the secretome of constructs exposed to simulated microgravity
conditions, medium from their culture environment was concentrated, due
to the large volume of liquid that they were suspended in inside the
rotating reactor vessels. 20 ml of incubation medium (40% of the total
volume that each group of constructs was cultured in) was acquired and
centrifuged at 220 G for 10min to remove large particles such as cell
membranes. The pellets were discarded and 15ml of the supernatant were
placed inside the upper chamber of individual Pierce™ Protein
Concentrator PES 10,000 MWCO tubes (Thermo Fisher Scientific, CA,
USA) to concentrate the proteins within the molecular size range of
interest. The samples were concentrated to 0.5 ml and were resuspended
in 10ml PBS and used for immunopurification.
For western blotting analysis, the medium was centrifuged at 220 × g
for 10 min and pellets were snap frozen at −80 °C for 30 min. They were
then rapidly pulverised using a multi-sample biopulverizer (BioSpec
Products Inc., OK, USA), suspended in 1.4 ml PBS and frozen at −20 °C
until processing.
Western blotting analysis
All samples were pre-labelled with a total protein stain, Cyanine 5, for 30min
(detected at 700 nm). Following labelling, samples were incubated with
dithiothreitol (DTT) and lithium dodecyl sulphate (LDS) loading buffer and
boiled for 5min at 90 °C. Samples were then spun at 14,000 x g for 1min
prior to loading onto 4–12% Bis-Tris 12 well NuPAGE gels run in MOPS (3-(N-
Morpholino)propanesulfonic acid) buffer, set at 180 V for 55min. Twenty
microlitres of the protein suspension was loaded per well from samples and
0.1 μg of pure protein. Gels were transferred onto nitrocellulose at 100 V for
1 h and blocked with 5% BSA for 2 h. Primary antibodies diluted as 1:1000 in
PBS+ 0.1% Tween were incubated with the blots for 1 h. The primary
antibodies used were polyclonal IgG rabbit anti-human PTH1R (N-terminus of
human parathyroid hormone receptor type 1); anti-human SOST (sequence
within the centre region of human Sclerostin) (Thermo Fisher Scientific,
Massachusetts, USA); anti-CX43 (phosphopeptide corresponding to amino
acid residues surrounding the phosphoserine 368 of connexin 43)
(Invitrogen, Life Technologies, Oregon, USA); and monoclonal IgG mouse
anti-human RANKL (clone 6A12.1, targeting an epitope within 95 amino acids
from the C-terminal region) (Merck KGaA, Darmstadt, Germany). Fluorescent
secondary antibodies—donkey anti-rabbit or anti-mouse IgG (800 nm)—
were incubated as 1:10,000 in PBS+ 0.1% Tween for 1 h. Rigorous washing
with PBS+ 0.1% Tween was carried out between steps. Blots were imaged
on a LI-COR Odyssey CLx (Licor Biosciences, Nebraska, USA) gel scanner at
700 nm (for total protein) and 800 nm (for specific antibody signal). A
Chameleon duo pre-stained protein ladder (Licor Biosciences, Nebraska, USA)
was used for reference. All blots derived from the same experiment were
processed in parallel.
Immunopurification of target proteins
Proteins of interest (Sclerostin, RANKL) were isolated from the concen-
trated culture medium of constructs by immunoprecipitation, using
methods described previously45, using 2.8 μm superparamagnetic Dyna-
beads (Invitrogen, Thermo Fisher Scientific, CA, USA), covalently coupled to
Protein G on their surface (~17 kDa). Goat polyclonal IgG antibodies
against human sclerostin (peptide with sequence C-PRARSAKANQAELEN,
from the C-terminus of SOST) and mouse IgG anti-RANKL (as above) were
used to isolate the proteins. Antibodies were attached to the magnetic
beads through their Fc region during a 15min incubation with rotation at
room temperature, by diluting into 200 μl of PBS containing 0.01% Tween-
20 and 0.09% sodium azide, in which 1.5 mg magnetic beads were
resuspended (Invitrogen, Thermo Fisher Scientific, CA, USA). The complex
formed was washed by resuspending in 200 μl buffer and 1000 μl of
concentrated medium was added to the formed Dynabeads-Ab complex.
Samples and complex were incubated for 15min at room temperature,
with rotation. The beads-Ab-protein complex was subsequently washed
four times using PBS washing buffer (Invitrogen, Thermo Fisher Scientific,
CA, USA). Finally, the Ab-protein complex was eluted from the beads
though the addition of 20 μl elution buffer (Invitrogen, Thermo Fisher
Scientific, CA, USA). For gel electrophoresis, samples were resuspended in a
loading mixture containing 2.5 μl NuPAGE LDS Sample buffer (4X), 1 μl
NuPAGE Reducing Agent (10X) (all from Thermo Fisher Scientific, CA, USA)
and 6.5 μl dH2O and were incubated for 10min at 70 °C. Samples were
loaded onto NuPAGE Novex 4–12% Bis-Tris Protein and were run at 160 V
for 60min using MOPS buffer. Five-hunded microlitres NuPage Antioxidant
(Thermo Fisher Scientific, CA, USA) was added to the buffer to maintain the
reduced state of proteins during protein gel electrophoresis. A Novex
Sharp pre-stained protein standard was used for reference (Thermo Fisher
Scientific, CA, USA). Pure medium from each category was run in parallel to
isolated protein samples.
Statistical analysis
Force measurements were acquired in triplicate (from three constructs). All
data is presented as mean ± SD. Statistical analysis was performed using a
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one-tailed distribution t-test, with a homoscedastic variance assumed. A
p-value lower than 0.05 was chosen for determining significance (MS
Excel, Washington, USA).
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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